Yi Da Selected Research

Pronase

1/2022

Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Da Research Topics

Disease

2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2022
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2019
1	Monoclonal Gammopathy of Undetermined Significance 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Paraproteinemias (Monoclonal Gammopathy) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2021
1	COVID-19 10/2021
1	Invasive Fungal Infections 08/2021
1	Plasma Cell Leukemia 02/2014
1	Hypercalcemia (Milk Alkali Syndrome) 02/2014
1	Renal Insufficiency (Renal Failure) 02/2014

Drug/Important Bio-Agent (IBA)

2	ChlorhexidineIBA 01/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	insulin-like growth factor binding protein-related protein 1IBA 01/2022
1	ParaffinIBA 01/2022
1	PronaseIBA 01/2022
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2014

Therapy/Procedure

1	Renal Dialysis (Hemodialysis) 01/2022
1	Organ Transplantation 08/2021